The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
Abstract
Several years ago, a comparison of the amino acid sequences of p53 proteins from a variety of species enabled us to reveal structural features of this protein, giving clues to its function. Since then, numerous studies on the biochemical, immunological and biological functions of p53 as well as on its structure (including crystallography data) have provided considerable insight into the multifunctional aspects of p53. The purpose of this review is to present the most recent data concerning the various structural features of the p53 protein with special emphasis on its flexibility, which plays a key role in regulation of its biological activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“…that binds to PCNA (Smith et al., 1994) but with a controversial role in DNA repair (Kazantsev & Sancar, 1995; Kearsey et al., 1995); the Bax gene (Miyashita & Reed, 1995), whose product is involved in the regulation of 0022–2836/96/300623–15 $18.00/0 7 apoptosis ; and the mdm2 gene , which…”
BackgroundInfluentialParticipation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 4×
“This hypothesis has been confirmed by crystallographic data (Cho et al., 1994).”
BackgroundInfluentialDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
The structure and function of proline-rich regions in proteins
Williamson, M. P. (1994) · Biochemical Journal · doi:10.1042/bj2970249 · Cited by 1,005
Interaction of the p53-Regulated Protein Gadd45 with Proliferating Cell Nuclear Antigen
Smith, M. L., Chen, I.-T., Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., & Fornace, A. J. (1994) · Science · doi:10.1126/science.7973727 · Cited by 944
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Mapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Lin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 653
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Structural aspects of the p53 protein in relation to gene evolution.
Soussi, T., de Fromentel, C. C., & May, P. (1990) · PubMed · Cited by 603
Self-citationHinds, P., Finlay, C., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 577
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Self-citationCrystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms
Jeffrey, P. D., Gorina, S., & Pavletich, N. P. (1995) · Science · doi:10.1126/science.7878469 · Cited by 549
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez, J., Georgoff, I., Martinez, J., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.2.151 · Cited by 527
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
Pavletich, N. P., Chambers, K. A., & Pabo, C. O. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2556 · Cited by 521
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J., & Shenk, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., & Anderson, C. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5041 · Cited by 487
Bergh, J., Norberg, T., Sjögren, S., Lindgren, A., & Holmberg, L. (1995) · Nature Medicine · doi:10.1038/nm1095-1029 · Cited by 460
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
Crawford, L. V., Pim, D. C., & Bulbrook, R. D. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910300404 · Cited by 450
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406
Lee, S., Elenbaas, B., Levine, A., & Griffith, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80006-6 · Cited by 405
Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
Hainaut, P. L., & Milner, J. (1993) · PubMed · Cited by 404
Inhibition of DNA replication factor RPA by p53
Dutta, A., Ruppert, J. M., Aster, J. C., & Winchester, E. (1993) · Nature · doi:10.1038/365079a0 · Cited by 374
Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6565 · Cited by 356
Multifactorial analysis of p53 alteration in human cancer: A review
Soussi, T., Legros, Y., Lubin, R., Ory, K., & Schlichtholz, B. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570102 · Cited by 353
Self-citationNuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins
Dang, C. V., & Lee, W. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84673-2 · Cited by 347
Jayaraman, L., & Prives, C. (1995) · Cell · doi:10.1016/s0092-8674(05)80007-8 · Cited by 345
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C., & Beach, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4766 · Cited by 342
Shaulian, E., Zauberman, A., Ginsberg, D., & Oren, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5581 · Cited by 342
Characterization of the human p53 gene.
Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 327
High-Resolution Structure of the Oligomerization Domain of p53 by Multidimensional NMR
Clore, G. M., Omichinski, J. G., Sakaguchi, K., Zambrano, N., Sakamoto, H., Appella, E., & Gronenborn, A. M. (1994) · Science · doi:10.1126/science.8023159 · Cited by 307
Feitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
Role of Cysteine Residues in Regulation of p53 Function
Rainwater, R., Parks, D., Anderson, M. E., Tegtmeyer, P., & Mann, K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3892 · Cited by 306
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., & Benchimol, S. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02287.x · Cited by 299
Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage
Cox, L. S., & Lane, D. P. (1995) · BioEssays · doi:10.1002/bies.950170606 · Cited by 287
Negative feedback regulation of wild-type p53 biosynthesis.
Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., & Deppert, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00123.x · Cited by 286
The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
Meek, D. W., Simon, S., Kikkawa, U., & Eckhart, W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07524.x · Cited by 277
Schlichtholz, B., Legros, Y., Gillet, D., Fruchart‐Gaillard, C., Marty, M. E., Lane, D. P., Calvo, F. M., & Soussi, T. (1992) · PubMed · Cited by 274
Self-citationBargonetti, J., Manfredi, J. J., Chen, X., Marshak, D. R., & Prives, C. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2565 · Cited by 265
Solution structure of the tetrameric minimum transforming domain of p53
Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D., & Arrowsmith, C. H. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-877 · Cited by 265
Liu, X., Miller, C. W., Koeffler, P. H., & Berk, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3291 · Cited by 260
Picksley, S. M., Vojtĕsek, B., Sparks, A., & Lane, D. P. (1994) · PubMed · Cited by 238
p53 point mutation and survival in colorectal cancer patients.
Goh, H. S., Yao, J. T. D., & Smith, D. R. (1995) · PubMed · Cited by 234
Transcriptional activation by p53 correlates with suppression of growth but not transformation
CROOK, T. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233
Stephen, C. W., & Lane, D. P. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90386-x · Cited by 210
Truant, R., Xiao, H., Ingles, C. J., & Greenblatt, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53769-8 · Cited by 203
Kao, C. C., Yew, P. R., & Berk, A. J. (1990) · Virology · doi:10.1016/0042-6822(90)90148-k · Cited by 202
Shaw, P., Freeman, J., Bovey, R., & Iggo, R. D. (1996) · PubMed · Cited by 202
Wild-type p53 adopts a ‘mutant’-like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193
A single gene and a pseudogene for the cellular tumour antigen p53
Zakut-Houri, R., Oren, M., Bienz, B., Lavie, V., Hazum, S., & Givol, D. (1983) · Nature · doi:10.1038/306594a0 · Cited by 192
Activation of the cryptic DNA binding function of mutant forms of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.14.3167 · Cited by 189
The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M. E., & Tegtmeyer, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9455 · Cited by 187
Hainaut, P. L., & Milner, J. (1993) · PubMed · Cited by 182
Horikoshi, N., Usheva, A., Chen, J., Levine, A. J., Weinmann, R., & Shenk, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.227 · Cited by 182
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M., & Adams, T. E. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.7.1601 · Cited by 174
Lubin, R., Schlichtholz, B., Bengoufa, D., Zalcman, G., Trédaniel, J., Hirsch, A., de Fromentel, C. C., Preudhomme, C., Fenaux, P., Fournier, G., et al. (1993) · PubMed · Cited by 173
Self-citationAnalysis of the gene coding for the murine cellular tumour antigen p53.
Bienz, B., Zakut-Houri, R., Givol, D., & Oren, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02110.x · Cited by 167
Ory, K., Legros, Y., Auguin, C., & Soussi, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06656.x · Cited by 163
Self-citationTan, T. H., Wallis, J., & Levine, A. J. (1986) · Journal of Virology · doi:10.1128/jvi.59.3.574-583.1986 · Cited by 162
p53 domains: structure, oligomerization, and transformation.
Wang, P., Reed, M., Wang, Y., Mayr, G., Stenger, J. E., Anderson, M. E., Schwedes, J. F., & Tegtmeyer, P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5182 · Cited by 161
Soussi, T., de Fromentel, C. C., Méchali, M., May, P., & Kress, M. (1987) · PubMed · Cited by 157
Self-citationPhosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.
Milne, D., Campbell, D. G., Caudwell, F. B., & Meek, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37101-6 · Cited by 154
Waterman, J. L. F., Shenk, J. L., & Halazonetis, T. D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07027.x · Cited by 144
Fiscella, M., Sj, U., Zambrano, N., Shields, M. T., Lin, D., Lees‐Miller, S. P., Anderson, C. W., Mercer, W. E., & Appella, E. (1993) · PubMed · Cited by 139
Post-translational modification of p53.
Meek, D. W. (1994) · PubMed · Cited by 139
A temperature‐sensitive mutant of human p53.
Zhang, W., Guo, X. Y., Hu, G., Liu, W. B., Shay, J. W., & Deisseroth, A. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06543.x · Cited by 139
Schlichtholz, B., Trédaniel, J., Lubin, R., Zalcman, G., Hirsch, A., & Soussi, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.159 · Cited by 139
Self-citationde Fromentel, C. C., Chandrasekaran, K., May, P., May-Levin, F., Mouriesse, H., & Lemerle, J. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390211 · Cited by 131
Self-citationImmunologically Distinct p53 Molecules Generated by Alternative Splicing
Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3232 · Cited by 128
Milne, D., Rh, P., Campbell, D. G., & Dw, M. (1992) · PubMed · Cited by 122
Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.
Oren, M., & Levine, A. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.56 · Cited by 119
Bayle, J. H., Elenbaas, B., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5729 · Cited by 119
Elledge, R. M., & Lee, W. (1995) · BioEssays · doi:10.1002/bies.950171105 · Cited by 118
Hupp, T. R., & Lane, D. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18165 · Cited by 118
Human p53 and CDC2Hs Genes Combine To Inhibit the Proliferation of Saccharomyces cerevisiae
Nigro, J. M., Sikorski, R. S., Reed, S. I., & Vogelstein, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1357 · Cited by 117
Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes
Milner, J. (1984) · Nature · doi:10.1038/310143a0 · Cited by 116
p53 binds to the TATA-binding protein-TATA complex
Martin, D. W., Muñoz, R. M., Subler, M. A., & Deb, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38619-3 · Cited by 113
A DNA binding domain is contained in the C-terminus ofwild typep53 protein
Foord, O., Bhattacharya, P., Reich, Z., & Rotter, V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.19.5191 · Cited by 113
Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein
Soussi, T., de Fromentel, C. C., Breugnot, C., & May, E. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.11384 · Cited by 111
Self-citationClinical utility of the immunocytochemical detection of p53 protein in cytological specimens.
Dowell, S. P., Wilson, P., Derias, N. W., Lane, D. P., & Hall, P. A. (1994) · PubMed · Cited by 110
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester, K., Lupold, S. E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., & Harris, C. C. (1995) · PubMed · Cited by 100
Sj, U., Mercer, W. E., & Appella, E. (1992) · PubMed · Cited by 99
The amino acid sequence of murine p53 determined from a c-DNA clone
Pennica, D., Goeddel, D. V., Hayflick, J. S., Reich, N. C., Anderson, C. W., & Levine, A. J. (1984) · Virology · doi:10.1016/0042-6822(84)90316-7 · Cited by 98
The human tumour suppressor gene p53 is alternatively spliced in normal cells.
Flaman, J., Waridel, F., Estreicher, A., Vannier, A., Limacher, J., Gilbert, D., Iggo, R. D., & Frébourg, T. (1996) · PubMed · Cited by 98
Ullrich, S. J., Sakaguchi, K., Lees‐Miller, S. P., Fiscella, M., Mercer, W. E., Anderson, C. W., & Appella, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5954 · Cited by 92
Jenkins, J. R., Chumakov, P. M., Addison, C. M., Stürzbecher, H. W., & Wade-Evans, A. M. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3903-3906.1988 · Cited by 89
The 53,000-dalton cellular protein and its role in transformation.
Crawford, L. (1983) · PubMed · Cited by 89
Flexibility: the key to p53 function?
Milner, J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88954-9 · Cited by 88
Tissue‐specific expression of p53 in transgenic mice is regulated by intron sequences
Lozano, G., & Levine, A. J. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040103 · Cited by 86
Human p53 Inhibits Growth in Schizosaccharomyces pombe
Bischoff, J. R., Casso, D. J., & Beach, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1405 · Cited by 84
Structure of the rat p53 tumor suppressor gene
Hulla, J. E., & Schneider, R. P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.3.713 · Cited by 83
Association of casein kinase II with immunopurified p53.
HERRMANN, C., Kraiss, S., & Montenarh, M. (1991) · PubMed · Cited by 82
Jenkins, J. R., Rudge, K., Redmond, S. M. S., & Wade‐Evans, A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5609 · Cited by 80
p53 is associated with p34cdc2 in transformed cells.
Milner, J., Cook, A., & Mason, J. M. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07478.x · Cited by 78
Legros, Y., Meyer, A., Ory, K., & Soussi, T. (1994) · PubMed · Cited by 76
Self-citationTemperature-dependent switching between “wild-type” and “mutant” forms of p53-Val135
Milner, J., & Medcalf, E. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90371-r · Cited by 73
Vojtěšek, B., Dolezalova, H., Lauerová, L., Svitáková, M., Havlis, P., Kovařík, J., Midgley, C. A., & Lane, D. P. (1995) · PubMed · Cited by 72
Phosphorylation sites in the amino-terminal region of mouse p53.
Wang, Y., & Eckhart, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4231 · Cited by 72
Kulesz-Martin, M. F., Lisafeld, B., Huang, H., Kisiel, N. D., & Lee, L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1698 · Cited by 71
Rainbow trout p53: cDNA cloning and biochemical characterization
de Fromentel, C. C., Pakdel, F., Chapus, A., Baney, C., May, P., & Soussi, T. (1992) · Gene · doi:10.1016/0378-1119(92)90383-z · Cited by 70
Self-citationMarston, N., Crook, T., & Vousden, K. H. (1994) · PubMed · Cited by 69
Ishioka, C., Englert, C., Winge, P., Yan, Y., Engelstein, M., & Friend, S. H. (1995) · PubMed · Cited by 68
The Tumor Suppressor p53 Is Bound to RNA by a Stable Covalent Linkage
Samad, A., & Carroll, R. B. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1598 · Cited by 64
Milner, J. (1991) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1991.0100 · Cited by 62
Legros, Y., Lafon, C., & Soussi, T. (1994) · PubMed · Cited by 62
Self-citationDoes the p53 Up-Regulated Gadd45 Protein Have a Role in Excision Repair?
Kazantsev, A. G., & Sancar, A. (1995) · Science · doi:10.1126/science.270.5238.1003 · Cited by 50
An intron binding protein is required for transformation ability of p53
Beenken, S. W., Karsenty, G., Raycroft, L., & Lozano, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.17.4747 · Cited by 45
Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein
Soussi, T., Begue, A., Kress, M., Stéhelin, D., & May, P. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.11383 · Cited by 39
Self-citationMilner, J. (1994) · PubMed · Cited by 39
Cloning of feline p53 tumor‐suppressor gene and its aberration in hematopoietic tumors
Okuda, M., Umeda, A., Sakai, T., Ohashi, T., Momoi, Y., Youn, H., WATARI, T., Goitsuka, R., Tsujtmoto, H., & Hasegawa, A. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580425 · Cited by 38
Hsp70 binds specifically to a peptide derived from the highly conserved domain (I) region of P53
Lam, K. T., & Calderwood, S. K. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91174-o · Cited by 37
Molinari, M., & Milner, J. (1995) · PubMed · Cited by 34
Legros, Y., Lacabanne, V., D'Agay, M. F., Larsen, C., Pla, M., & Soussi, T. (1993) · PubMed · Cited by 33
Self-citationLymphocyte stimulation: concanavalin A induces the expression of a 53K protein
Milner, J., & MCCORMICK, F. (1980) · Cell Biology International Reports · doi:10.1016/0309-1651(80)90205-2 · Cited by 31
Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53
Braithwaite, A. W., & Jenkins, J. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1792-1799.1989 · Cited by 30
The cDNA cloning and immunological characterization of hamster p53
Legros, Y., McIntyre, P., & Soussi, T. (1992) · Gene · doi:10.1016/0378-1119(92)90384-2 · Cited by 24
Self-citationThe rat genome contains a p53 pseudogene: detection of a processed pseudogene using PCR.Preprint
Hulla, J. E. (1992) · Genome Research · doi:10.1101/gr.1.4.251 · Cited by 24
Sequence analysis of canine p53 in the region of exons 3–8
Kraegel, S. A., Pazzi, K. A., & Madewell, B. R. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03779-v · Cited by 23
Rivkina, M., Cullen, J. M., Robinson, W. S., & Marion, P. L. (1994) · PubMed · Cited by 22
Nucleotide sequence of a cDNA encoding the monkey cellular phosphoprotein p53
Rigaudy, P., & Eckhart, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.20.8375 · Cited by 20
Wagner, P., Simanis, V., Maimets, T., Keenan, E., Addison, C. M., Brain, R., Grimaldi, M., Hw, S., & Jenkins, J. (1991) · PubMed · Cited by 16
Fukuda, I., & Ogawa, K. (1992) · Cell Structure and Function · doi:10.1247/csf.17.427 · Cited by 14
Elkind, N. B., Goldfinger, N., & Rotter, V. (1995) · PubMed · Cited by 11
Albor, A., Laborda, J., & Notario, V. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110309 · Cited by 9
Sequence of a cDNA encoding the p53 protein in Rhesus monkey (Macaca mulatta)
Kay, H. D., Mountjoy, C. P., Wu, G., Cornish, K. G., & Smith, L. J. (1994) · Gene · doi:10.1016/0378-1119(94)90812-5 · Cited by 5
(1990) · PubMed
Cited by
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Twenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Self-citationMDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 473
Metadata
- Authors
- Soussi, T., & May, P.
- Affiliations
- Inserm (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Soussi, Thierry
- ORCID
- Soussi, Thierry
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 260
- Issue
- 5
- Pages
- 623-637
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2012183441
- Cited by
- 208
- References
- 141
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 1 · 2018: 4 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 1
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ligue Contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, protein structure, gene evolution, protein flexibility, protein sequence comparison, crystallography, protein function, tumor suppressor
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cricetinae, Molecular Sequence Data, Phylogeny, Protein Conformation, Structure-Activity Relationship, Genes, p53, Tumor Suppressor Protein p53, Conserved Sequence, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Evolution, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.